Agios Pharmaceuticals Inc (AGIO)
29.51
+0.08
(+0.27%)
USD |
NASDAQ |
Apr 19, 13:22
Agios Pharmaceuticals Free Cash Flow (Quarterly): -72.72M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -72.72M |
| September 30, 2023 | -79.51M |
| June 30, 2023 | -66.74M |
| March 31, 2023 | -95.58M |
| December 31, 2022 | -66.28M |
| September 30, 2022 | -71.39M |
| June 30, 2022 | -76.16M |
| March 31, 2022 | -100.54M |
| December 31, 2021 | -88.60M |
| September 30, 2021 | -85.16M |
| June 30, 2021 | -117.54M |
| March 31, 2021 | -121.76M |
| December 31, 2020 | -49.96M |
| September 30, 2020 | -73.41M |
| June 30, 2020 | -71.94M |
| March 31, 2020 | -109.55M |
| December 31, 2019 | -100.29M |
| September 30, 2019 | -87.63M |
| June 30, 2019 | -89.42M |
| March 31, 2019 | -105.31M |
| December 31, 2018 | -75.24M |
| September 30, 2018 | -66.98M |
| June 30, 2018 | -68.76M |
| March 31, 2018 | -100.43M |
| Date | Value |
|---|---|
| December 31, 2017 | -75.73M |
| September 30, 2017 | -79.73M |
| June 30, 2017 | -60.02M |
| March 31, 2017 | -74.37M |
| December 31, 2016 | -52.44M |
| September 30, 2016 | -52.46M |
| June 30, 2016 | 155.09M |
| March 31, 2016 | -21.54M |
| December 31, 2015 | -32.72M |
| September 30, 2015 | -28.11M |
| June 30, 2015 | -6.902M |
| March 31, 2015 | -29.38M |
| December 31, 2014 | -9.264M |
| September 30, 2014 | -24.10M |
| June 30, 2014 | -1.157M |
| March 31, 2014 | -27.05M |
| December 31, 2013 | -13.84M |
| September 30, 2013 | -15.08M |
| June 30, 2013 | -16.52M |
| March 31, 2013 | -12.26M |
| December 31, 2012 | -11.66M |
| September 30, 2012 | -12.54M |
| June 30, 2012 | -10.83M |
| March 31, 2012 | -16.00M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-121.76M
Minimum
Mar 2021
-49.96M
Maximum
Dec 2020
-85.48M
Average
-85.16M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -45.10M |
| Blueprint Medicines Corp | -83.60M |
| Corcept Therapeutics Inc | 5.887M |
| Ionis Pharmaceuticals Inc | 32.89M |
| Madrigal Pharmaceuticals Inc | -80.97M |